Makes software that helps hospitals read DNA test results.
No change
Akre owns 3.7 million shares of SOPHiA Genetics, worth about $21 million. That’s less than $1 of every $100 they have in stocks. They didn’t really buy or sell any between April and June.
Mar 31
3,719,140
Jun 30
3,719,140
The numbers
Shares they own
3,719,140
Value on Jun 30, 2026
$21,459,438
about $21 million
Share of their money
0.4%
less than $1 of every $100 · 16th of 19
Price per share on Jun 30
$5.77
Kind
Shares
Also owned by
No other fund we follow
More about SOPHiA Genetics ›
The value uses the price on Jun 30, 2026. The fund may have paid a different price.